Agenus

$4.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-2.20%) Today
+$0.06 (+1.50%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Agenus and other stocks, options, and ETFs commission-free!

About AGEN

Agenus Inc. Common Stock, also called Agenus, is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA. The listed name for AGEN is Agenus Inc. Common Stock.

CEO
Garo H. Armen
Employees
328
Headquarters
Lexington, Massachusetts
Founded
1994
Market Cap
778.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.12M
High Today
$4.15
Low Today
$3.97
Open Price
$4.06
Volume
1.87M
52 Week High
$5.95
52 Week Low
$1.82

AGEN Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

GENC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure